Dr. Yonatan Mahller
I've won the following awards
Special Resident in Minimally Invasive Gynecologic Surgery, American Association of Gynecologic Laparoscopists
HealthTap Founding Doctor
Associations between DISC assessment and performance in obstetrics and gynecology residents.
The Journal of reproductive medicine, 56, 398-404 (2011)
Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 13, 886-97 (2011)
Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.
The journal of gene medicine, 12, 613-23 (2010)
Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
Clinical cancer research : an official journal of the American Association for Cancer Research, 15, 5840-51 (2009)
Targeting cancer-initiating cells with oncolytic viruses.
Molecular therapy : the journal of the American Society of Gene Therapy, 17, 1677-82 (2009)
Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.
PloS one, 4, e4235 (2009)
Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication.
Cancer gene therapy, 15, 733-41 (2008)
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
Molecular cancer therapeutics, 7, 1237-45 (2008)
Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamide.
Molecular therapy : the journal of the American Society of Gene Therapy, 16, 879-85 (2008)
Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.
Cancer research, 68, 1170-9 (2008)